0

The Latest “Buzz on the Street” Show: Featuring MediPharm Labs (TSX-V: LABS) Purchase Agreements

MediPharm Labs Corp. (TSX-V: LABS) (OTCQX: MEDIF) (FSE: MLZ) a global leader in specialized, research-driven cannabis extraction, distillation, purification and cannabinoid isolation, is pleased to announce that its wholly owned subsidiary, MediPharm Labs Inc., has entered into purchase agreements to secure a substantial 9,000 KG of dried cannabis supply from multiple cultivators in the last […]

0

The Latest “Buzz on the Street” Show: Featuring MediPharm Labs (TSX-V: LABS) Cannabinoid Production

MediPharm Labs Corp. (TSX-V: LABS) (OTCQX: MEDIF) (FSE: MLZ) a global leader in specialized, research-driven cannabis extraction, distillation, purification and cannabinoid isolation, is pleased to provide an update to investors on the significant strategic progress it is making, including with its successful ramp up of production capacity to supply its growing customer base. Founded in […]

0

The Latest “Buzz on the Street” Show: Featuring BevCanna Enterprises (CSE: BEV) Marketing Agreement

BevCanna Enterprises Inc. (“BevCanna” or the “Company”) (CSE: BEV), an emerging leader in infused innovations, is pleased to announce that it has signed an exclusive agreement for marketing services with award-winning branding agency, Dossier Creative. BevCanna Enterprises Inc. plans to develop and manufacture cannabinoid-infused beverages and consumer products for in-house brands and white label clients. […]

0

The Latest “Buzz on the Street” Show: Featuring BevCanna Enterprises (CSE: BEV) Appointment

BevCanna Enterprises Inc. (CSE: BEV) (OTC: BVNNF) announced that it has appointed top equity analyst Camilo Lyon to the Board of Directors and the audit committee of the Company, effective August 26, 2019. BevCanna Enterprises Inc. plans to develop and manufacture cannabinoid-infused beverages and consumer products for in-house brands and white label clients. With decades […]